HemaMax

recombinant human interleukin-12 · Neumedicines Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HemaMax, covering 2018-11-16 to 2018-11-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome [Phase 2]